Literature DB >> 17967427

Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.

Yu-Teh Li1, Su-Chen Li, Makoto Kiso, Hideharu Ishida, Laura Mauri, Laura Raimondi, Anna Bernardi, Sandro Sonnino.   

Abstract

The effect of inter-molecular carbohydrate-to-carbohydrate interaction on basic cell biological processes has been well documented and appreciated. In contrast, very little is known about the intra-molecular carbohydrate-to-carbohydrate interaction. The presence of an interaction between the GalNAc and the Neu5Ac in GM2 detected by NMR spectroscopy represents a well-defined intra-molecular carbohydrate-to-carbohydrate interaction. This intriguing interaction is responsible for the GM2-epitope, GalNAcbeta1-->4(Neu5Acalpha2-->3)Gal-, to exhibit a rigid and compact conformation. We hypothesized that this compact conformation may be the cause for both the GalNAc and the Neu5Ac in GM2 to be refractory to enzymatic hydrolysis and the GM2 activator protein is able to interact with the compact trisaccharide GM2-epitope, rendering the GalNAc and the Neu5Ac accessible to beta-hexosaminidase A and sialidase. We have used a series of structurally modified GM2 to study the effect of modifications of sugar chains on the conformation and enzymatic susceptibility of this ganglioside. Our hypothesis was borne out by the fact that when the GalNAcbeta1-->4Gal linkage in GM2 was converted to the GalNAcbeta1-->6Gal, both the GalNAc and the Neu5Ac became susceptible to beta-hexosaminidase A and sialidase, respectively, without GM2 activator protein. We hope our work will engender interest in identifying other intra-molecular carbohydrate-to-carbohydrate interactions in glycoconjugates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967427      PMCID: PMC2329919          DOI: 10.1016/j.bbagen.2007.09.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

1.  Crystal structure of human GM2-activator protein with a novel beta-cup topology.

Authors:  C S Wright; S C Li; F Rastinejad
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

2.  Synthesis and enzymatic susceptibility of a series of novel GM2 analogs.

Authors:  Tomoaki Fuse; Hiromune Ando; Akihiro Imamura; Naoki Sawada; Hideharu Ishida; Makoto Kiso; Takayuki Ando; Su-Chen Li; Yu-Teh Li
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

3.  Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.

Authors:  Y T Li; M Y Mazzotta; C C Wan; R Orth; S C Li
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

4.  Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain.

Authors:  L Svennerholm; J E Månsson; Y T Li
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

5.  A protein activator for the enzymic hydrolysis of GM2 ganglioside.

Authors:  S C Li; Y Hirabayashi; Y T Li
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

6.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.

Authors:  Y Hirabayashi; Y T Li; S C Li
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

8.  Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.

Authors:  E Conzelmann; K Sandhoff
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

9.  Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain.

Authors:  Yu-Teh Li; Karol Maskos; Chau-Wen Chou; Richard B Cole; Su-Chen Li
Journal:  J Biol Chem       Date:  2003-06-26       Impact factor: 5.157

10.  Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.

Authors:  P Hechtman; B A Gordon; N M Ng Ying Kin
Journal:  Pediatr Res       Date:  1982-03       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.